Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript
WAVE Life Sciences Reports First Quarter 2024 Financial Results
Wave Life Sciences | 10-Q: Quarterly report
Buy Rating Affirmed on Wave Life Sciences With Promising Obesity and AATD Programs
Express News | Wave Life Sciences Ltd : Raymond James Raises Target Price to $11 From $10
HHS Panel to Vote in Nov. on DMD Screening for Newborns
Earnings Call Summary | Wave Life Sciences(WVE.US) Q1 2024 Earnings Conference
The following is a summary of the Wave Life Sciences Ltd. (WVE) Q1 2024 Earnings Call Transcript:Financial Performance:Wave Life Sciences reported first quarter revenue of $12.5 million, primarily dri
Wave Life Sciences Ltd. (WVE) Q1 2024 Earnings Call Transcript
Wave Life Sciences Ltd. (WVE) Q1 2024 Earnings Call Transcript
Wave Life Sciences Releases Updated Corporate Overview
Earnings Flash (WVE) WAVE LIFE SCIENCES USA Posts Q1 Revenue $12.5M, Vs. Street Est of $23M
07:44 AM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (WVE) WAVE LIFE SCIENCES USA Posts Q1 Revenue $12.5M, vs. Street Est of $23M
Wave Life Sciences 1Q Research and Development Expenses $33.4M >WVE
Wave Life Sciences 1Q Research and Development Expenses $33.4M >WVE
Express News | Wave Life Sciences Ltd: Runway Expected Into 4Q 2025
WAVE Life Sciences Q1 EPS $(0.24) Misses $(0.21) Estimate, Sales $12.54M Miss $22.95M Estimate
WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 11.11 percent increase over losses of
Express News | Wave Life Sciences Q1 Net Income USD -31.558 Million Vs. Ibes Estimate USD -24 Million
Express News | Wave Life Sciences Q1 Operating Expenses USD 46.996 Million
Express News | Wave Life Sciences Q1 EPS USD -0.24 Vs. Ibes Estimate USD -0.21
Express News | Wave Life Sciences Q1 Revenue USD 12.538 Million Vs. Ibes Estimate USD 22.9 Million
Wave Life Sciences 1Q Loss/Shr 24c >WVE
Wave Life Sciences 1Q Loss/Shr 24c >WVE
Press Release: Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
RestorAATion-2 clinical trial of WVE-006 in AATD patients underway; expected proof-of-mechanism data in patients with AATD remains on track for 2024
No Data